Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Request a free trial

No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: zafirlukast

« Back to Dashboard
Zafirlukast is the generic ingredient in two branded drugs marketed by Par Pharm Inc and Dr Reddys Labs Ltd, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for zafirlukast. Three suppliers are listed for this compound.

Summary for Generic Name: zafirlukast

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list2
Suppliers / Packaging: see list9
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: zafirlukast

Clinical Trials for: zafirlukast

Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
Status: Completed Condition: Healthy

A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy
Status: Completed Condition: Allergic Asthma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-001Sep 26, 1996RXYes<disabled><disabled>
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-003Sep 17, 1999RXNo<disabled><disabled>
Dr Reddys Labs Ltd
ZAFIRLUKAST
zafirlukast
TABLET;ORAL090372-001Nov 18, 2010RXNo<disabled><disabled>
Dr Reddys Labs Ltd
ZAFIRLUKAST
zafirlukast
TABLET;ORAL090372-002Nov 18, 2010RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc